Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

about

Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment Hypothyroidism and Hypoparathyroidism in Thalassemia Major Patients: A Study in Sistan and Baluchestan Province, Iran.

P2860

Q35193628-26F7492B-7F1B-4306-B4B6-EB0C55563764 Q55034130-9C9ACE0B-3FC1-47E3-932C-AD5058F240B6

P2860

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

Item

http://www.wikidata.org/entity/Q37494096

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

@en

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea.

@nl

type

Item

label

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

@en

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea.

@nl

prefLabel

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

@en

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea.

@nl

P1476

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

@en

P2093

Ali Reza Makarem

http://www.w3.org/2001/XMLSchema#string

Mehran Karimi

http://www.w3.org/2001/XMLSchema#string

Omid Reza Zekavat

http://www.w3.org/2001/XMLSchema#string

Parvin Javad

http://www.w3.org/2001/XMLSchema#string

Sezaneh Haghpanah

http://www.w3.org/2001/XMLSchema#string

Zohreh Karamizadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major.

The beta-thalassemias.

Thalassemia intermedia: revisited.

Assessment of thyroid function in two hundred patients with beta-thalassemia major.

Reactivation of fetal hemoglobin in patients with beta-thalassemia.

Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience.

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia.

Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.

P304

60-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24453395

http://www.w3.org/2001/XMLSchema#string

P932

3895896

http://www.w3.org/2001/XMLSchema#string

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

about

P2860

P2860

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932